Bank of Ann Arbor’s GSK GSK Stock Holding History

Bank of Ann Arbor’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.26M	Buy	+26,077	New	+$1.33M	0.18%	106

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

Bank of Ann Arbor's GSK Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in GSK (GSK) in Q3 2026: 26,077 shares worth $1.26M. The stake represents 0.18% of the portfolio and ranks #106 among its holdings.

854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Bank of Ann Arbor held 26,077 shares of GSK worth $1.26M as of Q3 2026.
GSK was a new Bank of Ann Arbor position in Q3 2026.
GSK made up 0.18% of Bank of Ann Arbor's portfolio in Q3 2026, its #106 holding.
854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.